OMB APPROVAL
  UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 		OMB Number: 3235-0058
  Expires: February 28, 2022
  Estimated average burden hours per response. 2.50


  FORM 12b-25 SEC FILE NUMBER
 

 000-52069

 
    CUSIP NUMBER
  NOTIFICATION OF LATE FILING  

 

(Check one): [_] Form 10-K           [_] Form 20-F           [_] Form 11-K           [X] Form 10-Q           [_] Form 10-D
[_] Form N-CEN       [_] Form N-CSR
 
For Period Ended: December 31, 2019
[_] Transition Report on Form 10-K
[_] Transition Report on Form 20-F
[_] Transition Report on Form 11-K
[_] Transition Report on Form 10-Q
 
For the Transition Period Ended: ____________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type. 
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

 

 

  1  

 

PART I — REGISTRANT INFORMATION

 

Celexus, Inc.

Full Name of Registrant
 
 
Former Name if Applicable
 

8275 S. Eastern Ave. Suite 200

Address of Principal Executive Office (Street and Number)
 

Las Vegas, NV, 89123

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

  [X]   (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
    (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed)

The Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019 cannot be filed within the prescribed time period because the Company requires additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Form 10-Q.

 

  2  

 

PART IV — OTHER INFORMATION

           
(1) Name and telephone number of person to contact in regard to this notification
 
  Lisa Averbucho   (702)   675-8003
  (Name)   (Area Code)   (Telephone Number)
 
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
 
Yes  [X]     NO  [_]
 
   
 
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
 
Yes  [_]     NO  [X]
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

  3  

 

Celexus, Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  

February 14, 2020

  By: /s/ /s/ Lisa Averbucho
      Name:

Lisa Averbucho

      Title:

Chief Executive Officer

 

 

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

 

ATTENTION 
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001). 

Celexus (CE) (USOTC:CXUS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Celexus (CE) Charts.
Celexus (CE) (USOTC:CXUS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Celexus (CE) Charts.